; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (56) Spiromesifen Heading 9902.05.48 is amended— (A) by amending the article description to read as follows: [2-Oxo-3-(2,4,6-trimethylphenyl)-1-oxaspiro[4.4]non-3-en-4-yl] 3,3-dimethylbutanoate (Spiromesifen) (CAS No. 283594–90–1) (provided for in subheading 2932.20.10) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (57) Brodifacoum Heading 9902.05.50 is amended— (A) by amending the article description to read as follows: 4-Hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naph- thyl)coumarin (Brodifacoum) (CAS No. 56073–10–0) (provided for in subheading 2932.20.10) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (58) Sodium erythorbate Heading 9902.05.54 is amended— (A) by amending the article description to read as follows: Sodium erythorbate (sodium (2R)-2-[(2R)-4,5-dihydroxy- 3-oxo-2,3-dihydro-2-furanyl]-2-hydroxyethanolate) (CAS No. 6381–77–7) (provided for in subheading 2932.20.50) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (59) Pyraclostrobin technical Heading 9902.05.67 is amended— (A) by amending the article description to read as follows: Methyl N-(2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-phenyl)-(N-methoxy)carbamate (Pyraclostrobin) (CAS No. 175013–18–0) (provided for in subheading 2933.19.23) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (60) Triflumizole technical Heading 9902.05.74 is amended— (A) by amending the article description to read as follows: (E)-4-Chloro-α,α,α-trifluoro-N-(1-imidazol-1-yl-2- propoxyethylidene)-o-toluidine (Triflumizole) (CAS No. 99387–89–0) (provided for in subheading 2933.29.35) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (61) Fluopyram Heading 9902.05.80 is amended— (A) by amending the article description to read as follows: N-[2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2- (trifluoromethyl)benzamide (Fluopyram) (CAS No. 658066–35–4) (provided for in subheading 2933.39.21)